Get the Stockscreener App
1.47
5.16%
-0.08
After Hours:
1.47
Aptevo Therapeutics Inc stock is traded at $1.47, with a volume of 755.95K.
It is down -5.16% in the last 24 hours and up +2.80% over the past month.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
See More
Previous Close:
$1.55
Open:
$1.53
24h Volume:
755.95K
Relative Volume:
0.15
Market Cap:
$4.83M
Revenue:
$12.99M
Net Income/Loss:
$-23.72M
P/E Ratio:
-0.0151
EPS:
-97.2514
Net Cash Flow:
$-23.28M
1W Performance:
-2.00%
1M Performance:
+2.80%
6M Performance:
-85.31%
1Y Performance:
-99.20%
1-Day Range:
$1.45
$1.53
1-Week Range:
$1.39
$1.58
52-Week Range:
$1.32
$298.00
Aptevo Therapeutics Inc Stock (APVO) Company Profile
Name
Aptevo Therapeutics Inc
Sector
Industry
Phone
206-838-0500
Address
2401 4TH AVE., SEATTLE, WA
Compare APVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APVO
Aptevo Therapeutics Inc
|
1.47 | 21.40M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-18 | Initiated | Ladenburg Thalmann | Buy |
| Oct-05-17 | Resumed | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc Stock (APVO) Latest News
How to escape a deep drawdown in Aptevo Therapeutics Inc.Portfolio Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Statistical indicators supporting Aptevo Therapeutics Inc.’s strengthPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
How Aptevo Therapeutics Inc. (AP81) stock behaves under inflation pressure2025 Price Action Summary & AI Driven Price Predictions - newser.com
Aptevo Therapeutics Inc. stock chart pattern explained2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com
Combining machine learning predictions for Aptevo Therapeutics Inc.2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
How Aptevo Therapeutics Inc. stock reacts to oil prices2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com
Smart tools for monitoring Aptevo Therapeutics Inc.’s price action2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
Why Aptevo Therapeutics Inc. stock remains on watchlistsWeekly Stock Recap & Weekly High Conviction Trade Ideas - newser.com
Is Aptevo Therapeutics Inc. stock gaining market shareRisk Management & Expert Approved Momentum Trade Ideas - newser.com
Will Aptevo Therapeutics Inc. see short term momentumPortfolio Risk Report & Growth Focused Stock Pick Reports - newser.com
Trend analysis for Aptevo Therapeutics Inc. this week2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Why Aptevo Therapeutics Inc. stock appeals to analystsWeekly Loss Report & Reliable Trade Execution Plans - newser.com
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Published on: 2025-11-02 22:17:38 - newser.com
Is Aptevo Therapeutics Inc. (AP81) stock nearing a technical breakoutJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
How to integrate Aptevo Therapeutics Inc. into portfolio analysis toolsIndex Update & High Conviction Buy Zone Alerts - newser.com
Can Aptevo Therapeutics Inc. recover in the next quarterTake Profit & Safe Capital Growth Trade Ideas - newser.com
Why Aptevo Therapeutics Inc. stock remains a top recommendationDollar Strength & Consistent Return Investment Signals - newser.com
Can Aptevo Therapeutics Inc. stock hit analyst price targetsMarket Sentiment Review & Free Safe Entry Trade Signal Reports - newser.com
Can Aptevo Therapeutics Inc. stock attract ESG capital inflowsCPI Data & Fast Moving Trade Plans - newser.com
Measuring Aptevo Therapeutics Inc.’s beta against major indices2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Is Aptevo Therapeutics Inc. still worth holding after the dipWeekly Trend Summary & Daily Price Action Insights - newser.com
Aptevo Therapeutics Inc Stock (APVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):